ResearcherUniversity of Electronic Science and Technology of ChinaNo recent work listed
Yu Zhou
Matched on ORCID iD 0000-0002-0167-9997; OpenAlex author ID A5100613656. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2015: 4 papers · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 6
- Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. Co-author DOI 10.3892/ol.2018.8870↗
- Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2015.3292↗
- The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Co-author DOI 10.1186/s12967-015-0442-z↗
- High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-015-0490-4↗
- Metabolic phenotypes in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0115153↗
- Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. Co-author DOI 10.18632/oncotarget.5533↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhiqiang Fu · 5 shared papers, 2015–2018 · strength 0.25
- Paper Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. DOI 10.3892/ol.2018.8870↗
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Quanbo Zhou · 5 shared papers, 2015–2018 · strength 0.25
- Paper Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. DOI 10.3892/ol.2018.8870↗
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Rufu Chen · 4 shared papers, 2015–2018 · strength 0.21
- Paper Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. DOI 10.3892/ol.2018.8870↗
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Shangyou Zheng · 4 shared papers, 2015–2018 · strength 0.21
- Paper Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. DOI 10.3892/ol.2018.8870↗
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Wenchao Gao · 4 shared papers, 2015 · strength 0.17
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Paper Metabolic phenotypes in pancreatic cancer. DOI 10.1371/journal.pone.0115153↗
- Yimin Liu · 3 shared papers, 2015 · strength 0.13
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Paper Metabolic phenotypes in pancreatic cancer. DOI 10.1371/journal.pone.0115153↗
- Paper The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cance… DOI 10.1186/s12967-015-0442-z↗
- Yibiao Ye · 2 shared papers, 2015–2018 · strength 0.12
- Paper Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. DOI 10.3892/ol.2018.8870↗
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Yingxue Wang · 2 shared papers, 2015 · strength 0.09
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Xiaohui Zhao · 2 shared papers, 2015 · strength 0.09
- Paper High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarci… DOI 10.1186/s12967-015-0490-4↗
- Paper The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cance… DOI 10.1186/s12967-015-0442-z↗
- Huilin Ye · 2 shared papers, 2015 · strength 0.08
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Paper The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cance… DOI 10.1186/s12967-015-0442-z↗
- Zhihua Li · 2 shared papers, 2015 · strength 0.08
- Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
- Paper The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cance… DOI 10.1186/s12967-015-0442-z↗
- Tao Chen · 1 shared paper, 2018 · strength 0.08
- Shikai Zhu · 1 shared paper, 2016 · strength 0.06
- Heshui Wu · 1 shared paper, 2016 · strength 0.06
- Lei Zhao · 1 shared paper, 2015 · strength 0.05
- Langping Tan · 1 shared paper, 2015 · strength 0.04
- Min Yu · 1 shared paper, 2015 · strength 0.04
- Zhihua Li · 1 shared paper, 2015 · strength 0.04
- Rufu Chen · 1 shared paper, 2015 · strength 0.04
- Wenzhu Li · 1 shared paper, 2015 · strength 0.04
- Huimou Chen · 1 shared paper, 2015 · strength 0.04
- Jin-Long Zeng · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.